These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 24469444)

  • 41. Structural basis of pH-dependent antibody binding by the neonatal Fc receptor.
    Vaughn DE; Bjorkman PJ
    Structure; 1998 Jan; 6(1):63-73. PubMed ID: 9493268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Two-pronged Binding Mechanism of IgG to the Neonatal Fc Receptor Controls Complex Stability and IgG Serum Half-life.
    Jensen PF; Schoch A; Larraillet V; Hilger M; Schlothauer T; Emrich T; Rand KD
    Mol Cell Proteomics; 2017 Mar; 16(3):451-456. PubMed ID: 28062799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ligand binding and antigenic properties of a human neonatal Fc receptor with mutation of two unpaired cysteine residues.
    Andersen JT; Justesen S; Fleckenstein B; Michaelsen TE; Berntzen G; Kenanova VE; Daba MB; Lauvrak V; Buus S; Sandlie I
    FEBS J; 2008 Aug; 275(16):4097-110. PubMed ID: 18637944
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generation of mutated variants of the human form of the MHC class I-related receptor, FcRn, with increased affinity for mouse immunoglobulin G.
    Zhou J; Johnson JE; Ghetie V; Ober RJ; Ward ES
    J Mol Biol; 2003 Sep; 332(4):901-13. PubMed ID: 12972260
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single-chain variable fragment albumin fusions bind the neonatal Fc receptor (FcRn) in a species-dependent manner: implications for in vivo half-life evaluation of albumin fusion therapeutics.
    Andersen JT; Cameron J; Plumridge A; Evans L; Sleep D; Sandlie I
    J Biol Chem; 2013 Aug; 288(33):24277-85. PubMed ID: 23818524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Engineering human IgG1 affinity to human neonatal Fc receptor: impact of affinity improvement on pharmacokinetics in primates.
    Yeung YA; Leabman MK; Marvin JS; Qiu J; Adams CW; Lien S; Starovasnik MA; Lowman HB
    J Immunol; 2009 Jun; 182(12):7663-71. PubMed ID: 19494290
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Engineered soluble monomeric IgG1 CH3 domain: generation, mechanisms of function, and implications for design of biological therapeutics.
    Ying T; Chen W; Feng Y; Wang Y; Gong R; Dimitrov DS
    J Biol Chem; 2013 Aug; 288(35):25154-25164. PubMed ID: 23867459
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Computational determination of the structure of rat Fc bound to the neonatal Fc receptor.
    Weng Z; Gulukota K; Vaughn DE; Bjorkman PJ; DeLisi C
    J Mol Biol; 1998 Sep; 282(2):217-25. PubMed ID: 9735282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A strategy for bacterial production of a soluble functional human neonatal Fc receptor.
    Andersen JT; Justesen S; Berntzen G; Michaelsen TE; Lauvrak V; Fleckenstein B; Buus S; Sandlie I
    J Immunol Methods; 2008 Feb; 331(1-2):39-49. PubMed ID: 18155020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative studies of the serum half-life extension of a protein via site-specific conjugation to a species-matched or -mismatched albumin.
    Yang B; Kim JC; Seong J; Tae G; Kwon I
    Biomater Sci; 2018 Jul; 6(8):2092-2100. PubMed ID: 29881837
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of human IgG1 variant with enhanced FcRn binding and without increased binding to rheumatoid factor autoantibody.
    Maeda A; Iwayanagi Y; Haraya K; Tachibana T; Nakamura G; Nambu T; Esaki K; Hattori K; Igawa T
    MAbs; 2017 Jul; 9(5):844-853. PubMed ID: 28387635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insight into the avidity-affinity relationship of the bivalent, pH-dependent interaction between IgG and FcRn.
    Reusch J; Andersen JT; Rant U; Schlothauer T
    MAbs; 2024; 16(1):2361585. PubMed ID: 38849969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generation of a double transgenic humanized neonatal Fc receptor (FcRn)/albumin mouse to study the pharmacokinetics of albumin-linked drugs.
    Viuff D; Antunes F; Evans L; Cameron J; Dyrnesli H; Thue Ravn B; Stougaard M; Thiam K; Andersen B; Kjærulff S; Howard KA
    J Control Release; 2016 Feb; 223():22-30. PubMed ID: 26699424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn).
    Dall'Acqua WF; Kiener PA; Wu H
    J Biol Chem; 2006 Aug; 281(33):23514-24. PubMed ID: 16793771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Robust expression of the human neonatal Fc receptor in a truncated soluble form and as a full-length membrane-bound protein in fusion with eGFP.
    Seijsing J; Lindborg M; Löfblom J; Uhlén M; Gräslund T
    PLoS One; 2013; 8(11):e81350. PubMed ID: 24260574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Direct demonstration of a neonatal Fc receptor (FcRn)-driven endosomal sorting pathway for cellular recycling of albumin.
    Schmidt EGW; Hvam ML; Antunes F; Cameron J; Viuff D; Andersen B; Kristensen NN; Howard KA
    J Biol Chem; 2017 Aug; 292(32):13312-13322. PubMed ID: 28637874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Albumin binding to FcRn: distinct from the FcRn-IgG interaction.
    Chaudhury C; Brooks CL; Carter DC; Robinson JM; Anderson CL
    Biochemistry; 2006 Apr; 45(15):4983-90. PubMed ID: 16605266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of receptor dimerization on the interaction between the class I major histocompatibility complex-related Fc receptor and IgG.
    Raghavan M; Wang Y; Bjorkman PJ
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11200-4. PubMed ID: 7479965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Humanized FcRn mouse models for evaluating pharmacokinetics of human IgG antibodies.
    Proetzel G; Roopenian DC
    Methods; 2014 Jan; 65(1):148-53. PubMed ID: 23867339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The influence of antibody engineering on Fc conformation and Fc receptor binding properties: Analysis of FcRn-binding engineered antibodies and an Fc fusion protein.
    Suzuki T; Hashii N; Tada M; Ishii-Watabe A
    MAbs; 2021; 13(1):1923366. PubMed ID: 34030575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.